UnitedHealth has been recovering from its atrocious start to 2025. Its CEO was brutally murdered in New York City early in 2025 and management changes and scandals have only added insult on top of injury to UnitedHealth’s battered shareholders. After peaking at $630, it lost nearly two-thirds of its value – but now it has staged a massive recovery.
UnitedHealth may be in a situation where not all bad news stories last forever. Its shares have made a substantial recovery of more than 50% from the recent lows. And now Wall Street analysts keep raising their price targets for the nation’s top health insurer.
One critical boost came when Warren Buffett’s Berkshire Hathaway disclosed that it had taken a stake in UnitedHealth. The view of Oggonomics was that it may have been more of a symbolic stake rather than a declaration of “All Clear!” to the public. That said, its stock has risen handily since that news broke.
After UNH stock bottomed at about $235.00 on August 1, the recovery of 20% in August was followed by another 12% gain in September. And the stock was up another 8% in October at the time of this reporting with shares last seen at $373.
Oggonomics saw many analyst price target hikes in September. More than a half-dozen analyst price target hikes have been tracked in October, and the month is only about one-third of the way through. UnitedHealth will release its third quarter earnings report before the opening bell on Tuesday, October 28, 2025. Does this mean that Wall Street has signaled an “all clear” sign for strategic investors?
Please note that the analyst ratings and price targets mentioned below are assigned to each firm making their calls. Oggonomics does not maintain any rating or price target of its own on UnitedHealth or its competitors. These are the UNH price target changes that have been just so far in the month of October:
- JP Morgan (Overweight) target raised to $425 from $310 on 10/09
- Mizuho (Outperform) target raised to $430 from $300 on 10/09
- Barclays (Overweight) target raised to $386 from $352 on 10/09
- BofA Securities (Neutral) target raised to $390 from $350 on 10/08
- Bernstein (Outperform) target raised to $433 from $379 on 10/08
- KeyBanc Capital Markets (Overweight) target raised to $400 from $350 on 10/08
- Wells Fargo (Overweight) target raised to $400 from $267 on 10/07
UNH has a 52-week trading range of $234.60 to $630.73 and a market cap of $338 billion based on its current $373 share price.
For a further disclaimer, please note that Wall Street analysts can get their thesis wrong just like the rest of the investing community. And they never issue any statements with guaranteed profits or money-back guarantees in their reports. And as always, company fundamentals and market sentiment can change in an instant.
